Novartis

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novartis and other ETFs, options, and stocks.

About NVS

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. 

CEO
Vasant Narasimhan
CEOVasant Narasimhan
Employees
104,323
Employees104,323
Headquarters
Basel, Basel-Stadt (Basle Town)
HeadquartersBasel, Basel-Stadt (Basle Town)
Founded
1996
Founded1996
Employees
104,323
Employees104,323

NVS Key Statistics

Market cap
185.19B
Market cap185.19B
Price-Earnings ratio
7.25
Price-Earnings ratio7.25
Dividend yield
2.90
Dividend yield2.90
Average volume
2.34M
Average volume2.34M
High today
$76.62
High today$76.62
Low today
$75.37
Low today$75.37
Open price
$75.54
Open price$75.54
Volume
3.65M
Volume3.65M
52 Week high
$94.26
52 Week high$94.26
52 Week low
$74.09
52 Week low$74.09

NVS News

Benzinga 22h
European Drug Makers Say Higher Energy Costs Eating Margins: Report

by Europe's drug makers have warned about stopping manufacturing some cheap generic medicines amid surging electricity costs. The generic drug industry lobby...

European Drug Makers Say Higher Energy Costs Eating Margins: Report
MarketWatch 5d
Novartis outlines plan to become a 'top-five player' in U.S. pharmaceuticals market

Novartis AG NOVN, -0.89% on Thursday told investors that the Swiss drug maker plans to adopt a "U.S.-first mindset" in its bid to become a "top-five player" in...

Novartis outlines plan to become a 'top-five player' in U.S. pharmaceuticals market
Benzinga 6d
Novartis Unveils New Strategy Focused On US-First, Eight Blockbuster Brands

Novartis AG (NYSE: NVS) has revealed insights into the updated company strategy. The company said that a 'US-first' mindset, increasing the share of U.S. patien...

Novartis Unveils New Strategy Focused On US-First, Eight Blockbuster Brands

Analyst ratings

50%

of 26 ratings
Buy
38.5%
Hold
50%
Sell
11.5%

NVS Earnings

$0.00
$0.57
$1.14
$1.71
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Available Oct 25, Pre-Market
ActualAvailable Oct 25, Pre-Market

More NVS News

Reuters 6d
Novartis to take U.S. drug patent case to Supreme Court - Reuters

ZURICH, Sept 21 (Reuters) - Novartis AG (NOVN.S) plans to ask the U.S. Supreme court to uphold the validity of a patent it holds on the dosing reg...

Novartis to take U.S. drug patent case to Supreme Court - Reuters
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.